» Articles » PMID: 33569599

Pirh2, an E3 Ligase, Regulates the AIP4-p73 Regulatory Pathway by Modulating AIP4 Expression and Ubiquitination

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2021 Feb 11
PMID 33569599
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Pirh2 is an E3 ligase belonging to the RING-H2 family and shown to bind, ubiquitinate and downregulate p73 tumor suppressor function without altering p73 protein levels. AIP4, an E3 ligase belonging to the HECT domain family, has been reported to be a negative regulatory protein that promotes p73 ubiquitination and degradation. Herein, we found that Pirh2 is a key regulator of AIP4 that inhibits p73 function. Pirh2 physically interacts with AIP4 and significantly downregulates AIP4 expression. This downregulation is shown to involve the ubiquitination of AIP4 by Pirh2. Importantly, we demonstrated that the ectopic expression of Pirh2 inhibits the AIP4-p73 negative regulatory pathway, which was restored when depleting endogenous Pirh2 utilizing Pirh2-siRNAs. We further observed that Pirh2 decreases AIP4-mediated p73 ubiquitination. At the translational level and specifically regarding p73 cell cycle arrest function, Pirh2 still ensures the arrest of p73-mediated G1 despite AIP4 expression. Our study reveals a novel link between two E3 ligases previously thought to be unrelated in regulating the same effector substrate, p73. These findings open a gateway to explain how E3 ligases differentiate between regulating multiple substrates that may belong to the same family of proteins, as it is the case for the p53 and p73 proteins.

Citing Articles

DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities.

Abuetabh Y, Wu H, Chai C, Al Yousef H, Persad S, Sergi C Exp Mol Med. 2022; 54(10):1658-1669.

PMID: 36207426 PMC: 9636249. DOI: 10.1038/s12276-022-00863-4.


The Role of E3 Ligase Pirh2 in Disease.

Daks A, Fedorova O, Parfenyev S, Nevzorov I, Shuvalov O, Barlev N Cells. 2022; 11(9).

PMID: 35563824 PMC: 9101203. DOI: 10.3390/cells11091515.


Regulation of p73 by Pirh2-AIP4 loop.

Wu H, Abou Zeinab R, Leng R Aging (Albany NY). 2021; 13(17):20858-20859.

PMID: 34520394 PMC: 8457594. DOI: 10.18632/aging.203537.


p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies.

Horvat A, Tadijan A, Vlasic I, Slade N Cancers (Basel). 2021; 13(12).

PMID: 34207603 PMC: 8227208. DOI: 10.3390/cancers13122885.

References
1.
Hakem A, Bohgaki M, Lemmers B, Tai E, Salmena L, Matysiak-Zablocki E . Role of Pirh2 in mediating the regulation of p53 and c-Myc. PLoS Genet. 2011; 7(11):e1002360. PMC: 3219591. DOI: 10.1371/journal.pgen.1002360. View

2.
Logan I, Gaughan L, McCracken S, Sapountzi V, Leung H, Robson C . Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer. Mol Cell Biol. 2006; 26(17):6502-10. PMC: 1592843. DOI: 10.1128/MCB.00147-06. View

3.
Puig P, Capodieci P, Drobnjak M, Verbel D, Prives C, Cordon-Cardo C . p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer. Clin Cancer Res. 2003; 9(15):5642-51. View

4.
Vikhreva P, Melino G, Amelio I . p73 Alternative Splicing: Exploring a Biological Role for the C-Terminal Isoforms. J Mol Biol. 2018; 430(13):1829-1838. PMC: 5995411. DOI: 10.1016/j.jmb.2018.04.034. View

5.
Jost C, Marin M, Kaelin Jr W . p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature. 1997; 389(6647):191-4. DOI: 10.1038/38298. View